Figure 4 | Scientific Reports

Figure 4

From: Comparative Meta-Analysis of Tenofovir Disoproxil Fumarate versus Emtricitabine and Tenofovir Disoproxil Fumarate as Treatments for Patients with Chronic Hepatitis B

Figure 4

Forest plot displaying the secondary outcomes of safety assessment for CHB patients after treatments with TDF alone and FTC/TDF combination, respectively.

Forest plot showed the comparison of (a) overall AE, (b) drug-related AE, (c) SAE and (d) drug-related SAE for CHB patients after treatments with TDF alone and FTC/TDF combination, respectively.

Back to article page